COVID-19 vaccine
‘Eye of the storm’: Diverse east London grapples with virus
Taxicab driver Gary Nerden knows colleagues who got seriously ill from COVID-19. He knows the area of east London where he lives and works has among the highest infection rates in the whole of England. But since he can’t afford not to work, he drives around picking up strangers for up to 12 hours a day, relying on a flimsy plastic screen to keep him safe.
Study finds 'Oxford vaccine' may reduce virus transmission
AstraZeneca’s COVID-19 vaccine does more than prevent people from falling seriously ill — it appears to reduce transmission of the virus and offers strong protection for three months on just a single dose, researchers said Wednesday in an encouraging turn in the campaign to suppress the outbreak.
COVAX publishes 1st interim distribution forecast
The Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance and the World Health Organisation, as co-leads of the COVAX initiative for equitable global access to COVID-19 vaccines, alongside key delivery partner UNICEF, on Wednesday published COVAX’s first interim distribution forecast.
Oxford-AstraZeneca vaccine OK for all adults: S Korea panel
A South Korean panel of experts has said that vaccines for the novel coronavirus by AstraZeneca can be administered to elderly people amid efficacy controversies, according to the country's drug safety agency Monday.
Hungary, Bolivia want COVID-19 vaccine from Bangladesh: Shahriar Alam
Hungary and Bolivia have sought COVID-19 vaccine from Bangladesh, State Minister for Foreign Affairs Shariar Alam has told Parliament.
Anti-vaccine protesters temporarily shut down vaccine site
One of the largest vaccination sites in the country temporarily shut down Saturday because dozen of protesters blocked the entrance, stalling hundreds of motorists who had been waiting in line for hours, the Los Angeles Times reported.
‘Simple is beautiful’: One-shot vaccine proves effective
The first one-shot COVID-19 vaccine provides good protection against the illness, Johnson & Johnson reported in a key study released Friday, offering the world a potentially important new tool as it races to stay ahead of the rapidly mutating virus.
EU regulator authorizes AstraZeneca vaccine for all adults
Regulators authorized AstraZeneca’s coronavirus vaccine for use in adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population.
Johnson & Johnson’s 1-dose shot prevents COVID-19
Johnson & Johnson’s long-awaited vaccine appears to protect against COVID-19 with just one shot – not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses.
German draft doesn’t recommend AstraZeneca jab for over-65s
A draft recommendation from Germany’s vaccination advisory committee calls for offering the AstraZeneca vaccine only to people aged 18-64 for now, citing what it says is insufficient data to judge its effectiveness for older people.